Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(67 sites)
United States
Ellison Clinic at Saint John's, Los Angeles, California UCSF Medical Center at Mission Bay, San Francisco, California University of Colorado Cancer Center, Aurora, Colorado Yale-New Haven Hospital, New Haven, Connecticut Florida Cancer Specialists ORLANDO/DDU, Lake Mary, Florida Moffitt Cancer Center, Tampa, Florida Winship Cancer Institute, Emory University, Atlanta, Georgia University of Iowa, Iowa City, Iowa Louisiana State University Health Sciences Center, New Orleans, Louisiana Massachusetts General Hospital, Boston, Massachusetts Dana-Farber Cancer Institute, Boston, Massachusetts Barbara Ann Karmanos Cancer Institute, Detroit, Michigan START Midwest, Grand Rapids, Michigan Saint Luke's Cancer Institute, Kansas City, Missouri Washington University, St Louis, Missouri Memorial Sloan Kettering Cancer Center, New York, New York UH Cleveland Medical Center, Cleveland, Ohio Stefanie Spielman Comprehensive Breast Center, Columbus, Ohio Providence Cancer Institute Franz Clinic, Portland, Oregon The West Clinic, PLLC dba West Cancer Center, Germantown, Tennessee Sarah Cannon Research Institute, Nashville, Tennessee Mary Crowley Cancer Research Center, Dallas, Texas Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, Texas University of Texas Southwestern, Dallas, Texas University of Texas MD Anderson Cancer Center, Houston, Texas START San Antonio, San Antonio, Texas START Mountain Region, West Valley City, Utah University of Vermont Medical Center, Burlington, Vermont USO-Virginia Cancer Specialists, PC, Fairfax, Virginia Belgium
Institut Jules Bordet, Anderlecht France
Institut Bergonié - Centre Régional de Lutte Contre Le Cancer de Bordeaux et Sud Ouest, Bordeaux Institut Paoli-Calmettes, Marseille Centre Antoine-Lacassagne, Nice Institut Claudius Regaud, Toulouse Gustave Roussy, Villejuif Germany
Universitätsklinikum Erlangen, Erlangen Universitätsmedizin Mannheim, Mannheim Ireland
Mater Misericordiae Hospital, Dublin Italy
Azienda Ospedaliera Nazionale Santi Antonio e Biagio e Cesare Arrigo, Alessandria Spedali Civili di Brescia, Brescia Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan Istituto Europeo di Oncologia, Milan Fondazione IRCCS San Gerardo dei Tintori, Monza Azienda Ospedaliero Universitaria Pisana - Stabilimento Santa Chiara, Pisa Ospedale Santa Maria delle Croci, Ravenna Fondazione Policlinico Universitario Agostino Gemelli, Roma Centro Ricerche Cliniche di Verona s.r.l., Verona Japan
National Hospital Organization Kyushu Cancer Center, Fukuoka Kansai Medical University Hospital, Hirakata The Cancer Institute Hospital of JFCR, Kōtō City Kyoto University Hospital, Kyoto Netherlands
Netherlands Cancer Institute, Amsterdam Spain
Hospital Quiron Barcelona, Barcelona South Texas Accelerated Research Therapeutics (START) Barcelona- HM Nou Delfos, Barcelona Instituto Oncologico Dr Rosell (IOR), Barcelona Hospital Universitari Vall d'Hebron, Barcelona Hospital San Pedro, Logroño MD Anderson Cancer Center, Madrid Hospital Clinico San Carlos, Madrid Hospital Universitario Fundación Jiménez Díaz, Madrid Hospital Universitario HM Sanchinarro, Madrid Hospital Universitario Quironsalud Madrid, Pozuelo de Alarcón Hospital Universitari Sant Joan de Reus, Reus Hospital Universitario Virgen Macarena, Seville